TriSalus Life Sciences, Inc.

TLSI · Nasdaq · SIC 3841: Surgical & Medical Instruments & Apparatus
128
SEC Filings

Business Summary

TriSalus Life Sciences, Inc. is an oncology-focused medical technology company that develops innovative drug delivery technologies for solid tumors. Its flagship product, the TriNav Infusion System, uses Pressure-Enabled Drug Delivery (PEDD) technology for interventional radiology procedures including TACE and TARE. The company also develops nelitolimod, an investigational TLR9 agonist, and the PRVI device for pancreatic tumor treatment, generating $45.2 million in TriNav revenue in 2025.

Next Earnings

Q2 FY2026 — expected 2026-09-23

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTLSIdiscussed_in_filing Cybersecurity
topic_mentionTLSIdiscussed_in_filing Trusted Computing
topic_mentionTLSIdiscussed_in_filing Blockchain & Crypto
topic_mentionTLSIdiscussed_in_filing Supply Chain
topic_mentionTLSIdiscussed_in_filing Regulation
topic_mentionTLSIdiscussed_in_filing Healthcare & Bio
topic_mentionTLSIdiscussed_in_filing Platform & Ecosystem
topic_mentionTLSIdiscussed_in_filing Cybersecurity
topic_mentionTLSIdiscussed_in_filing Trusted Computing
topic_mentionTLSIdiscussed_in_filing Blockchain & Crypto
topic_mentionTLSIdiscussed_in_filing Supply Chain
topic_mentionTLSIdiscussed_in_filing Regulation
topic_mentionTLSIdiscussed_in_filing Healthcare & Bio
topic_mentionTLSIdiscussed_in_filing Platform & Ecosystem
topic_mentionTLSIdiscussed_in_filing Cybersecurity
topic_mentionTLSIdiscussed_in_filing Trusted Computing
topic_mentionTLSIdiscussed_in_filing Blockchain & Crypto
topic_mentionTLSIdiscussed_in_filing Supply Chain
topic_mentionTLSIdiscussed_in_filing Regulation
topic_mentionTLSIdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001628280-26-015163EDGAR85K words
2025-04-152024-12-310001826667-25-000030EDGAR—
2024-04-112023-12-310001826667-24-000005EDGAR—
2023-03-222022-12-310001410578-23-000332EDGAR—
2022-03-032021-12-310001410578-22-000252EDGAR—
2021-03-312020-12-310001104659-21-044719EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001628280-25-052043EDGAR25K words
2025-08-122025-06-300001826667-25-000117EDGAR—
2025-05-152025-03-310001826667-25-000051EDGAR—
2024-11-142024-09-300001826667-24-000051EDGAR—
2024-08-142024-06-300001826667-24-000039EDGAR—
2024-05-152024-03-310001826667-24-000017EDGAR—
2023-11-142023-09-300001826667-23-000007EDGAR—
2023-08-022023-06-300001410578-23-001525EDGAR—
2023-05-122023-03-310001410578-23-001035EDGAR—
2022-11-102022-09-300001410578-22-003118EDGAR—
2022-08-102022-06-300001410578-22-002206EDGAR—
2022-05-112022-03-310001410578-22-001311EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001628280-26-015155EDGAR5K words
2026-02-200001493152-26-007598EDGAR—
2026-02-090001628280-26-006219EDGAR—
2026-01-120001628280-26-001743EDGAR—
2025-11-130001628280-25-052008EDGAR—
2025-10-010001628280-25-043440EDGAR—
2025-08-290001826667-25-000129EDGAR—
2025-08-120001826667-25-000115EDGAR—
2025-07-240001826667-25-000103EDGAR—
2025-06-230001826667-25-000077EDGAR—

128 total filings indexed. 100 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

MMM — 3M CO ARAY — ACCURAY INC AEMD — AETHLON MEDICAL INC ALUR — ALLURION TECHNOLOGIES, INC. ANGO — ANGIODYNAMICS INC AORT — ARTIVION, INC. RCEL — AVITA Medical, Inc. ADGM — Adagio Medical Holdings, Inc.

Tags

oncology---liver-cancer-(hcc,-icc,-liver-metastases) oncology---pancreatic-cancer-(pdac) interventional-radiology uterine-artery-embolization thyroid-artery-embolization prostate-embolization genicular-artery-embolization-for-osteoarthritis fda-510(k)-clearance toll-like-receptor-9-(tlr9)-agonist-platform immune-checkpoint-inhibitor-(cpi)-combination-therapy

Company Identity

CIK0001826667
TickerTLSI
ExchangeNasdaq
SIC3841: Surgical & Medical Instruments & Apparatus
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b5554badc6204781d9c3ae8c28fb55576a4ad6a95b3d6a190f74c1c1af961ca0
parent: b2205826ef4dac393b8f84d62571e4ed1938619eff07d1fb7afbecb5dd5cfc6b
content hash: e34034cce3eb182f27a4cdf025e29d57828259df6e20dc9b0a8313629edef11d
signed: 2026-04-13T04:47:49.336Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf